Loading...
NYSE: CC
The Chemours Company
Basic Materials · Chemicals - Specialty
Market Cap
$2.85B
52w High
$21.85
52w Low
$9.13
P/E
-7.41
Volume
3.06M
Outstanding Shares
150.09M
Company profile
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America.
CEODenise Dignam
SectorBasic Materials
IndustryChemicals - Specialty
Employees6,000
IPO dateJun 19, 2015
Valuation
Forward P/E—
EV/EBITDA17.13
Enterprise value$5.69B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-4.59%
Gross margin15.53%▼21.98%vs FY2024
Operating margin-0.09%▼101.12%vs FY2024
ROE-154.4%▼1184.39%vs FY2024
Analyst consensus
RatingHold
Target price$18.86▼0.84%
9
Buy
10
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
View
EPS
Actual vs estimate by quarter
Q3'25
ActualEst.
$0.58
$0.46
Q4'25
ActualEst.
$0.20
$0.24
Q1'26
ActualEst.
$0.05
$0.09
Q1FY25
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3'25
ActualEst.
$1.62B
$1.54B
Q4'25
ActualEst.
$1.5B
$1.33B
Q1'26
ActualEst.
$1.33B
$1.42B
Q1FY25
Next Est.
—